Cachet Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002462.SZ

Cachet Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.95

Cachet Pharmaceutical Co., Ltd. Debt to Equity Ratio is 0.95 for the year ending December 31, 2023, a -9.64% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Cachet Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 1.05, a 1.80% change year over year.
Cachet Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 1.03, a -1.07% change year over year.
Cachet Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 1.04, a 3.00% change year over year.
Cachet Pharmaceutical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 1.01, a -24.16% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Shenzhen Stock Exchange: 002462.SZ

Cachet Pharmaceutical Co., Ltd.

CEO	Mr. Yibin Huang
IPO Date	Aug. 18, 2010
Location	China
Headquarters	Building 1
Employees	2,357
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Cachet Pharmaceutical Co., Ltd. engages in the wholesale and retail sale of pharmaceutical products in China. It is involved in the supply of medicines to hospitals; wholesale of biological products, medical instruments, and traditional Chinese medicines; pharmaceutical logistic operations; and manufacture of medicines. The company owns 150 chain stores in Beijing that sell medicines, health care foods, medical instruments, cosmetics, daily necessities, and traditional Chinese medicines. Cachet Pharmaceutical Co., Ltd. was founded in 1998 and is based in Beijing, China.

Key trends

Past 5 years